- Home
- GNSS vs GNTA Comparison
GNSS vs GNTA Comparison
Compare GNSS & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNSS
- GNTA
- Stock Information
- Founded
- GNSS 1992
- GNTA 2014
- Country
- GNSS United States
- GNTA Italy
- Employees
- GNSS N/A
- GNTA N/A
- Industry
- GNSS Consumer Electronics/Appliances
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GNSS Consumer Staples
- GNTA Health Care
- Exchange
- GNSS Nasdaq
- GNTA Nasdaq
- Market Cap
- GNSS 169.5M
- GNTA 67.4M
- IPO Year
- GNSS N/A
- GNTA 2021
- Fundamental
- Price
- GNSS $3.75
- GNTA $5.34
- Analyst Decision
- GNSS Strong Buy
- GNTA Strong Buy
- Analyst Count
- GNSS 3
- GNTA 1
- Target Price
- GNSS $5.08
- GNTA $25.00
- AVG Volume (30 Days)
- GNSS 106.7K
- GNTA 28.4K
- Earning Date
- GNSS 12-05-2024
- GNTA 01-01-0001
- Dividend Yield
- GNSS N/A
- GNTA N/A
- EPS Growth
- GNSS N/A
- GNTA N/A
- EPS
- GNSS N/A
- GNTA N/A
- Revenue
- GNSS $27,968,000.00
- GNTA N/A
- Revenue This Year
- GNSS N/A
- GNTA N/A
- Revenue Next Year
- GNSS $138.10
- GNTA N/A
- P/E Ratio
- GNSS N/A
- GNTA N/A
- Revenue Growth
- GNSS N/A
- GNTA N/A
- 52 Week Low
- GNSS $1.51
- GNTA $2.20
- 52 Week High
- GNSS $4.04
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- GNSS 60.29
- GNTA 56.89
- Support Level
- GNSS $3.67
- GNTA $4.89
- Resistance Level
- GNSS $3.94
- GNTA $6.20
- Average True Range (ATR)
- GNSS 0.14
- GNTA 0.70
- MACD
- GNSS -0.02
- GNTA -0.06
- Stochastic Oscillator
- GNSS 77.78
- GNTA 37.32
About GNSS Genasys Inc.
Genasys Inc is a provider of critical communications solutions designed to help keep people safe. The company is engaged in the design, development, and commercialization of directed and multidirectional sound technologies, voice broadcast products and location-based mass messaging solutions for emergency warning and workforce management. Its operating segment includes Hardware and Software. The company generates maximum revenue from the Hardware segment. Geographically, it derives a majority of revenue from the Americas region and also has its presence in the Asia Pacific and Europe, Middle East and Africa.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.